Brief: Glenmark Pharma Initiates Multi-Country Phase 3 Clinical Trial For Envafolimab
05/09/2025 06:47
Sept 5 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: GLENMARK PHARMA - GLENMARK INITIATES MULTI-COUNTRY PHASE 3 CLINICAL TRIAL FOR ENVAFOLIMAB GLENMARK PHARMA - DCGI GRANTS NO OBJECTION CERTIFICATE TO COMMENCE ENROLLMENT IN INDIA GLENMARK PHARMA - CLINICAL TRIAL APPLICATIONS UNDERWAY IN RUSSIA, BRAZIL, MEXICO Source text: [ID:] Further company coverage: GLEN.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter